本文選題：腸腫瘤 + 中醫(yī)傳承輔助平臺��； 參考：《腫瘤學(xué)雜志》2017年02期

【摘要】：[目的]分析預(yù)防治療結(jié)直腸癌患者復(fù)發(fā)轉(zhuǎn)移的中藥的用藥規(guī)律。[方法]收集經(jīng)病理診斷結(jié)直腸癌患者的中藥處方321張,運用《中醫(yī)傳承輔助平臺系統(tǒng)》(Ⅴ2.5)對數(shù)據(jù)進(jìn)行用藥規(guī)律挖掘,分析藥物頻次、關(guān)聯(lián)規(guī)則和核心組合。[結(jié)果]共納入中藥處方321張,涉及中藥164味,用藥頻次3908次。使用頻次最高的藥物分別為甘草、太子參、茯苓、白術(shù)、半夏、當(dāng)歸、黃柏、薏苡仁、黃芩、肉桂。預(yù)防結(jié)直腸癌復(fù)發(fā)轉(zhuǎn)移組的核心藥對為太子參-白術(shù)-茯苓-甘草-黃柏-半夏-黃芩-肉桂。治療結(jié)直腸癌復(fù)發(fā)轉(zhuǎn)移組的核心藥對為太子參-白術(shù)-茯苓-甘草-當(dāng)歸-黃芩-黃柏-蒼術(shù)。[結(jié)論]辨治結(jié)直腸癌多用補氣健脾、溫補腎陽、清熱解毒、疏肝理氣藥物。
[Abstract]:[objective] to analyze the law of drug use of traditional Chinese medicine for prevention of recurrence and metastasis of colorectal cancer patients. [methods] 321 prescriptions of traditional Chinese medicine (TCM) for pathological diagnosis of colorectal cancer were collected. The data were excavated with the help platform of traditional Chinese Medicine (鈪，

本文編號：1876838